Form D · Biotechnology
TVAX Biomedical, Inc.
Olathe, KS · CIK 0001526959
Offering snapshot reported Jul 7, 2016 · SEC filing
- Reported sold
- $325K Offering amount: $500K
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 23, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 7, 2016 | Initial | $325,075 | No comparison | 14 | SEC filing |
| Dec 13, 2012 | Initial | $2,027,318 | No comparison | 29 | SEC filing |
| Jul 29, 2011 | Initial | $0 | No comparison | 135 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-266528
Source: Form D, filed Jul 7, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Charles Burton | Director |
| Wesley E. Griffitt | Director |
| Philip Haworth | Executive |
| Catherine E. Lucasey | Director, Executive |
| Barry S. Skikne | Director |
| Lowell L. Tilzer | Director, Executive |
| Tammie A. Wahaus | Executive |
| Rex E. Wiggins | Director, Executive |
| Gary W. Wood | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
10900 S. Clay Blair Blvd. Suite 700
Olathe, KS, 66061
Olathe, KS, 66061